|4Dec 19, 4:15 PM ET

Dunne Michael W. 4

4 · Iterum Therapeutics plc · Filed Dec 19, 2023

Insider Transaction Report

Form 4
Period: 2023-12-18
Transactions
  • Purchase

    Ordinary Shares

    2023-12-18$1.84/sh+10,000$18,44288,754 total
Footnotes (1)
  • [F1]The price reported is a weighted average price. The securities were purchased in multiple transactions at per share prices ranging from $1.795 to $1.85. The Reporting Person undertakes to provide upon request of the SEC staff, the Issuer, or any shareholder of the Issuer, full information requiring the number of securities purchased at each separate price within the range set forth in this footnote.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION